Saturday Morning Organic connections Dr. Huber 2012 Agronomic Part 1.mp4 – Video


Saturday Morning Organic connections Dr. Huber 2012 Agronomic Part 1.mp4
To view part 2 http://youtu.be/ZTBgP6ZiKYs Agronomic Opportunities For Organic Agriculture on the Prairies DR DONALD M. HUBER, Emeritus Professor of Plant Pathology, Purdue University Dr....

By: Organic Connections

Originally posted here:
Saturday Morning Organic connections Dr. Huber 2012 Agronomic Part 1.mp4 - Video

Gene screen eyes mainstream

Genome sequencing holds great potential for diagnosing diseases, finding treatments and ultimately cutting medical costs, experts say, but insurance companies are leery of covering the still-new procedure, preventing it so far from becoming a routine part of medical care.

Boston-based Partners HealthCare is one of just two systems in the country to offer full genome sequencing for clinical patients. The out-of-pocket cost of unlocking your full genetic code, though, is steep: $9,000.

Cost is a barrier, said Heidi Rehm, chief laboratory director at the Partners Center for Personalized Genetic Medicine in Cambridge.

The lab started offering full genome sequencing last August using blood samples to extract information from DNA but it has done the complex analysis for fewer than half a dozen patients since then. Insurance companies didnt cover the costs for any of those patients, Rehm said.

For patients suffering from a range of diseases, from cancer to hearing loss, sequencing can help identify the gene causing the problem and help doctors determine which treatments will be most effective. Genetic sequencing can also tell patients if theyre at risk of developing certain conditions later in life.

The challenge for scientists like Rehm is to prove that this kind of analysis is useful not just for sick patients but for healthy ones.

Can I say every patient should get their genome sequenced? We just dont have the collective evidence and the studies to prove that today, Rehm said. So the insurers are not going to cover everything today.

Insurance companies do pay for some genetic tests those that test specifically for a patients risk of developing breast cancer, for example but theyre still evaluating the benefit of full genome sequencing, which involves much more data and analysis.

We dont have a lot of information yet to make sweeping decisions, said Dr. Neil Minkoff, medical director for the Massachusetts Association of Health Plans. We tend to look at the individual patient or individual physicians request. Its still early in our experience with it.

The states three largest insurers, Blue Cross Blue Shield, Harvard Pilgrim Health Care and Tufts Health Plan, did not respond to requests for comment.

Continued here:
Gene screen eyes mainstream

Sugar industry can be revived with the help of Tissue Culture & Genetic Engineering in UP. – Video


Sugar industry can be revived with the help of Tissue Culture Genetic Engineering in UP.
02 February 2014, Shri Narendra Modi highlight the growth of cooperatives in Gujarat which along with focusing on tissue culture, genetic engineering and dri...

By: Bharatiya Janata Party

Go here to read the rest:
Sugar industry can be revived with the help of Tissue Culture & Genetic Engineering in UP. - Video

131 student projects win awards at Fayette County science fair

Monisha Rekhraj, a senior at Paul Laurence Dunbar High School, talked about her project with judge Brett Spear during the 30th Annual Kentucky American Water Science Fair at Bryan Station High School, where about 655 Fayette County public, private and home-school students in grades four through 12 competed for awards on Saturday. Rekhraj's project tested the effect of an anti-cancer agent on another disease. HERALD-LEADER|BuyPhoto

About 685 public, private and home-school students in grades 4 through 12 participated Saturday in the 30th annual Kentucky American Water Science Fair at Bryan Station High School in Lexington. The event included 650 projects judged by about 160 professionals, the company said in a news release. A total of 131 student projects received awards. See a list of the winners (PDF).

Judges evaluated the student projects according to the following categories: animal sciences, behavioral and social sciences, biochemistry, cellular and molecular biology, chemistry, computer science, earth and planetary science, engineering, energy and transportation, environmental sciences, medicine and health sciences, microbiology, physics and astronomy and plant sciences.

Kentucky American Water initiated the science fair for junior high school students in 1985 as part of the companys centennial celebration. The next year, the company joined with Fayette County Public Schools in coordinating the event. The fair has been expanded twice: first in 1989 to include elementary school science projects, and again in 1991 to include high school projects, according to the news release.

Students who received awards at Saturday's competition advance to the Central Kentucky Regional Science and Engineering Fair to be held at the University of Kentucky on March 1.

Read the rest here:
131 student projects win awards at Fayette County science fair

Nanomedicine Market is Expected to Reach USD 177.60 Billion in 2019

Albany, NY (PRWEB) February 07, 2014

According to a new market report published by Transparency Market Research "Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019," the market for nanomedicine was valued at USD 78.54 billion in 2012 and is expected to reach a value of USD 177.60 billion in 2019, growing at a CAGR of 12.3% from 2013 to 2019.

Browse the full report with complete TOC at http://www.transparencymarketresearch.com/nanomedicine-market.html

The advent of new applications and technology in the field of nanomedicine will be one of the major growth factors for the global nanomedicine market. In addition, increase of funding aimed at boosting the research activities pertaining to nanomedicine by the government as well as private institutions will expedite the process of commercialization of new products and hence will drive the market. Other driving factors include rising base of geriatric population, presence of high unmet medical needs and rising worldwide incidences of chronic diseases.

The global nanomedicine market by applications was dominated by the oncology market with a market share of approximately 38.0% in 2012 on account of the presence of high number of commercialized products in this segment. Development of nanomedicine products enabling drugs crossing blood brain barrier and targeting the tumor in brain and at other sites in the body will prove to be a significant future growth driver for this market.

Related Report: Gastrointestinal Endoscopic Devices Market http://www.transparencymarketresearch.com/gastrointestinal-endoscopic-devices.html

However, the global cardiovascular market for nanomedicine is the fastest growing application segment. Factors such as the presence of large patient prevalence coupled with rising demand for nanotechnology enabled drugs and devices catering to this segment, attribute to its high growth rate.

North America dominated the market in 2012 and is expected to maintain its market position till 2019. However, theAsia-Pacific market is estimated to grow at a faster pace (CAGR of 14.6% from 2013 to 2019).Europe is expected to grow at a relatively higher rate compared to North America owing to constantly improving regulatory framework and the presence of an extensive product pipeline portfolio.

Some of the key players in the global nanomedicine market include GE Healthcare, Merck & Co Inc., Abbott Laboratories, Pfizer Inc., Nanosphere Inc., Mallinckrodt plc, Teva Pharmaceutical Industries Ltd., Sigma-Tau Pharmaceuticals Inc., Celgene Corporation, Novavax, Inc.; Life Technologies, MagArray, Inc., Gilead Sciences Inc. and others.

Blog: http://www.tmrblog.com/ Blog: http://www.culrav.org/pr/author/tmrrelease

Read more from the original source:
Nanomedicine Market is Expected to Reach USD 177.60 Billion in 2019

Caitlyn Brennan: Dust to dust

I am an atheist. While atheism and agnosticism are much on the rise in the United States, particularly among people my age, most people remain religiously affiliated. I rarely find that my atheism angers religious people I meet. However, I am often met with (what I perceive to be) pity. The pity is not so much for the fact that I dont share in their particular religious beliefs, but that I dont possess any at all. Whether talking to a Catholic or Muslim or Jew or Sikh or whomever, when the subject of religion is breached, it often seems theyd rather I say Im any religion rather than none. They speak of a void that can only be filled by God/religion/faith, and when I tell them my void is indeed perfectly full, they dont believe me. Their disbelief is magnified if I tell them about my loss of a parent.

My father died when I was 20. Though he died abruptly, I am fortunately able to say I have few regrets. There were no missed I love yous or agonizing loose ends left untied. We were extremely close, and we were extremely happy. In all honesty, this makes it more difficult to deal with his death. I feel robbed. I mourn his loss extensively, and sometimes I do search for something bigger to hold my faith.

Im often told by others to seek solace in knowing Ill see him again someday, but I cant. I know that I will never see him again. I dont believe in heaven or hell, in an afterlife where everyone youve ever lost is waiting patiently for your arrival. I believe when we die, we rot into the ground, decomposed by bacteria and bugs, to return back into the earth.

Many people of faith find this haunting and tragic dismally sad and cynical. But I believe it is beautiful.

While unable to find comfort in the idea of being posthumously reunited with my late father, I find great relief in knowing that his body, as mine and yours and everyones, will be the stuff of which new life generates. Im calmed by the idea that in the grand scheme of the universe, we are small; that nothing is unique, and that nature reigns. That electrons spin around nuclei just as planets orbit stars, and that the veins in my body branch out, tinier and tinier, remarkably similar to the branches which turn into sticks and twigs on trees.

Our thoughts are just the products of electrical firings and chemical interactions, as are our beating hearts, and when these things stop, so begins a process by nature of breaking down and building back up, to create more thoughts and more heartbeats, more veins, more trees. We die, but our parts and pieces our atoms stay here. I dont just believe, but know, that in this way, my father never really left. He will always be around me.

While science has no god and I await no messiah, I have faith in it. I am able to find great contentment in the truths it has to offer me. Questions about where the universe came from or the exact origin of life or what our Greater Purpose is dont faze me. Some of these things I dont believe Im capable of knowing in my lifetime, while other things I happily seek answers to through exploring that which I find fulfilling and relevant. Im at no loss and suffer no profound confusion as to the meaning of life.

Im happy for the religious who peacefully explore their faith and what it has to offer them, and I ask that they afford me the same. Dont feel bad for me because I dont believe in God, and dont dismiss my faith because it relies on the physical rather than the spiritual. Indeed, put simply, when I say I have faith, believe me.

Caitlyn Brennan can be reached at caibre@umich.edu.

Read the original post:
Caitlyn Brennan: Dust to dust

The personalized and the personal: Socially responsible innovation through big data – Video


The personalized and the personal: Socially responsible innovation through big data
The possibility of creating data products and services fueled by fine-grained behavioral information, and informed by behavioral science and choice architect...

By: DeloitteLLP

Read more:
The personalized and the personal: Socially responsible innovation through big data - Video

Digital Health: Changing Medical Schools Forever

YouTube Videos Tweets Comments

Anatomy, physiology and introduction to clinical medicine, move over!

This year, medical futurist Bertalan Mesko, MD launches a new course, Disruptive Technologies in Medicine with Professor Maria Judit Molnar, the scientific Vice Rector of Semmelweis University, Budapest, Hungary. His goal is to prepare medical students for those future technologies they will face by the time they start actually practicing medicine. Dr. Mesko wants to persuade them that the relation between the human touch and technologies can work together to advance clinical science and care.

The curriculum touches on many of the digital health hot buttons found in the conversations of todayand, if Mesko has his way, these topics will find their way to the conversations at bedside too.

International students will access materials online as well. They will learn and compete against each other by answering questions about the future of medicine using the course social media page on Facebook. Further, new global collaborations with the students in digital health medical classes will be fostered, including courses byKim Solez, Professor of Anatomical Physiology at the University of Alberta. More collaborations are planned.

The role of digital health is taking root. From investments byGoogle, Apple and other large voices in the marketplace to a true global presence, its only a matter of time until medical education catches up with this powerful trend.

Keep Critical! Follow me onTwitter,LinkedInandGoogle+!

Source: Forbes

Go here to see the original:
Digital Health: Changing Medical Schools Forever